Fragmin and Biopsy breast abnormal - a phase IV clinical study of FDA data


Biopsy breast abnormal is reported only by a few people who take Fragmin.

The phase IV clinical study analyzes which people take Fragmin and have Biopsy breast abnormal. It is created by eHealthMe based on reports of 10,589 people who have side effects while taking Fragmin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 13, 2022

10,589 people reported to have side effects when taking Fragmin.
Among them, 3 people (0.03%) have Biopsy breast abnormal.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 10,689 Fragmin users for its effectiveness, alternative drugs and more.

What is Biopsy breast abnormal?

Biopsy breast abnormal is found to be associated with 392 drugs and 162 conditions by eHealthMe.

Number of Fragmin and Biopsy breast abnormal reports submitted per year:

Could Fragmin cause Biopsy breast abnormal?

Time on Fragmin when people have Biopsy breast abnormal *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Biopsy breast abnormal when taking Fragmin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Fragmin *:

  1. Mirena: 3 people, 100.00%
  2. Gilenya: 3 people, 100.00%
  3. Buscopan: 3 people, 100.00%

Common side effects people have besides Biopsy breast abnormal *:

  1. White Blood Cell Count Decreased: 3 people, 100.00%
  2. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 100.00%
  3. Nausea (feeling of having an urge to vomit): 3 people, 100.00%
  4. Nasopharyngitis (inflammation of the nasopharynx): 3 people, 100.00%
  5. Muscle Aches (muscle pain): 3 people, 100.00%
  6. Lymphocyte Count Decreased: 3 people, 100.00%
  7. Joint Pain: 3 people, 100.00%
  8. Headache (pain in head): 3 people, 100.00%
  9. Hair Loss: 3 people, 100.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 100.00%

Common conditions people have *:

  1. Pain In Extremity: 3 people, 100.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 100.00%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 100.00%
  4. Birth Control: 3 people, 100.00%
  5. Gastric Disorder (disease of stomach): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and have Biopsy breast abnormal?

Check whether Biopsy breast abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Biopsy breast abnormal and when was it recovered:

Expand to all the drugs that have ingredients of dalteparin sodium:

Alternative drugs to, pros and cons of Fragmin:

Common Fragmin side effects:

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Biopsy breast abnormal treatments and more:

COVID vaccines that are related to Biopsy breast abnormal:

Common drugs associated with Biopsy breast abnormal:

All the drugs that are associated with Biopsy breast abnormal:

Common conditions associated with Biopsy breast abnormal:

All the conditions that are associated with Biopsy breast abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium (the active ingredients of Fragmin) and Fragmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: